129 related articles for article (PubMed ID: 38311970)
1. Piperlongumine, a
Luo N; Zhang L; Xiu C; Luo X; Hu S; Ji K; Liu Q; Chen J
Food Funct; 2024 Feb; 15(4):2154-2169. PubMed ID: 38311970
[TBL] [Abstract][Full Text] [Related]
2. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
Chen G; Xu Q; Dai M; Liu X
Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
[TBL] [Abstract][Full Text] [Related]
3. Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
Qian Z; Zhong Z; Ni S; Li D; Zhang F; Zhou Y; Kang Z; Qian J; Yu B
J Cell Mol Med; 2020 Sep; 24(17):10112-10127. PubMed ID: 32790170
[TBL] [Abstract][Full Text] [Related]
4. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
5. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
7. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
8. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
[TBL] [Abstract][Full Text] [Related]
9. Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
Yuan SG; Hu HL; Wang XJ; Yang JC; Zhou RP; Bai XC; Lai PL
Orthop Surg; 2022 Jun; 14(6):1203-1216. PubMed ID: 35470579
[TBL] [Abstract][Full Text] [Related]
10. Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
Sun P; Yang Q; Wang Y; Peng J; Zhao K; Jia Y; Zhang T; Lu X; Han W; Qian Y
Drug Des Devel Ther; 2020; 14():4189-4203. PubMed ID: 33116407
[TBL] [Abstract][Full Text] [Related]
11. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways.
Cang D; Zou G; Yang C; Shen X; Li F; Wu Y; Ji B
J Pharmacol Sci; 2021 Aug; 146(4):206-215. PubMed ID: 34116734
[TBL] [Abstract][Full Text] [Related]
12. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
[TBL] [Abstract][Full Text] [Related]
14. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
[TBL] [Abstract][Full Text] [Related]
15. Water Extract of
Gu DR; Yang H; Kim SC; Hwang YH; Ha H
Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079923
[No Abstract] [Full Text] [Related]
16. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
17. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
18. Cumambrin A prevents OVX-induced osteoporosis
Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
[TBL] [Abstract][Full Text] [Related]
19. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
Yang T; Chen W; Gan K; Wang C; Xie X; Su Y; Lian H; Xu J; Zhao J; Liu Q
J Transl Med; 2023 Nov; 21(1):839. PubMed ID: 37993937
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
